Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Home Exercise vs PT for Reverse Total Shoulder Arthroplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03719859
Recruitment Status : Recruiting
First Posted : October 25, 2018
Last Update Posted : October 6, 2020
Sponsor:
Collaborator:
Orthopedic Research and Education Foundation
Information provided by (Responsible Party):
Rush University Medical Center

Brief Summary:
The primary objective of this study is to compare outcomes between formal clinic based physical therapy (PT) rehabilitation and surgeon directed home therapy (HT) after reverse total shoulder arthroplasty (RSA) as measured by pain, range of motion, Single Assessment Numerical Evaluation (SANE), and American Shoulder and Elbow Surgery (ASES) scores at 6 weeks, 3, 6, 12, and 24 months postoperatively. The secondary objective of this study is to determine if PT rehabilitation following RSA is associated with a higher level of postoperative complications, specifically acromial stress fractures or dislocation. This information will be useful to discern if PT is effective in providing pain relief more quickly, as well as improved motion and self-reported functional outcomes following RSA, which can assist surgeons and rehabilitation specialists in designing optimal care plans for this patient population. The project will also help to clarify if PT services place patients who have RSA at higher risk for acromial stress fractures or dislocation.

Condition or disease Intervention/treatment Phase
Shoulder Arthritis Rotator Cuff Tear Arthropathy Other: Physical Therapy Other: Home Therapy Not Applicable

Detailed Description:

Reverse total shoulder arthroplasty (RSA) is a relatively new solution for the patient with osteoarthritis of the glenohumeral joint with a deficient rotator cuff, or patients with glenohumeral osteoarthritis with excessive erosion of the posterior glenoid. Since the approval of RSA in 2003, the utility has increased such that this procedure represented 33% of all shoulder arthroplasties performed in the United States in 2011, and represents greater than 90% in some European countries The RSA prosthesis is effective at providing improved active motion and function due the semi-constrained design--substituting for the centering effect of the rotator cuff and allowing the deltoid to elevate or abduct the arm with fixed-fulcrum kinematics without a functional rotator cuff. Many factors influence the potential for successful outcome following RSA: proper patient selection, surgeon experience level, prosthesis characteristics, surgical technique and approach, and postoperative rehabilitation. Prior researchers have explored the effect of surgical technique, type of prosthesis, and surgery indications on outcome following RSA, however there is no data published on the impact of postoperative rehabilitation following this surgery.

A systematic review of the literature reveals that complications following RSA occur with four times greater incidence than complications following anatomic total shoulder arthroplasty (TSA). Complications following RSA which may be impacted by the exercises associated with physical therapy include instability and acromion stress fractures. A systematic review of the literature was conducted to determine if complication rates following RSA differ due to surgical approach, type of prosthesis (medialized or lateralized center of rotation), and the indication for the procedure. The authors of this review acknowledge that postoperative rehabilitation can impact the clinical and functional outcome of RSA and complication rate, however did not study this variable due to the heterogeneous approach to rehabilitation for the multi-center study.

Experts in the field of shoulder rehabilitation have published clinical guidelines for rehabilitation following reverse shoulder arthroplasty. One set of published guidelines is based on biomechanical and basic science healing timeframes associated with the tissue attrition following RSA. The authors describe precautions to protect the prosthesis from dislocation and acromial stress fractures, and propose a slow progressive approach to restoring motion and functional strength. The clinical guidelines published by these authors contrast with a very progressive criterion based rehabilitation plan that allows early use of the arm and very little immobilization. Neither of these two proposed rehabilitation plans are associated with clinical trials that track clinical or functional outcome measures or complication rate. A chapter devoted to rehabilitation following RSA in the book "Reverse Shoulder Arthroplasty" suggests that physician directed video-based rehabilitation may be just as effective as formal physical therapy. The author points out the need for randomized controlled trials to determine the need for physical therapy following a variety of shoulder surgeries. Clarifying the impact of formal clinic based PT intervention following RSA is important in determining the best plan of care for this population following surgery, while ensuring that there is not an increase in complications associated with the therapy.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Patients will be randomized to one of two groups (surgeon directed home therapy or formal physical therapy). If subjects in either group are dissatisfied with the outcome of their rehabilitation process, they will be afforded the opportunity to cross-over to the other arm of the study.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Multicenter Randomized Trial of Home vs. Physical Therapist-Directed Rehabilitation for Reverse Total Shoulder Arthroplasty
Actual Study Start Date : January 22, 2019
Estimated Primary Completion Date : June 30, 2021
Estimated Study Completion Date : October 31, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Physical Therapy (PT) Group
Subjects will attend formal physical therapy after surgery.
Other: Physical Therapy
Subjects who will participate in the physical therapy intervention group will attend therapy 4-6 days after discharge from the hospital, and continue in therapy approximately once a week for three months. The physical therapy progression will follow the standard of care developed at Duke Sports Medicine Physical Therapy for rehabilitation following RSA. Some of the patients in the PT intervention cohort may have physical therapy at an institution outside of Midwest Orthopaedics at Rush. All patients, whether in the Rush system or outside, will be given a prescription with the identical instructions for "physical therapy, status post (R/L) reverse total shoulder arthroplasty, 1-2 x per week x 12 weeks."
Other Name: PT

Active Comparator: Home Therapy (HT) Group
Subjects will receive instruction from clinical staff regarding home therapy exercises after surgery.
Other: Home Therapy
The surgeon/Nurse Practitioner/Physician Assistant will advance rehabilitation exercises and activity guidelines at customary scheduled postoperative appointments for this surgical procedure: 2 weeks (+/- 5 days), 6 weeks (+/- 1 week), 3 months and 6 months (+/- 1 month), and 1 and 2 years (+/- 2 months).
Other Name: HT




Primary Outcome Measures :
  1. Postoperative Pain: Numerical Rating Scale [ Time Frame: up to 2 years postoperatively ]
    Pain measured using 0-10 Numeric Pain Rating Scale (NRS) with 0 being a better score

  2. Range of motion [ Time Frame: up to two years postoperatively ]
    Clinician measure of function using active and passive forward elevation, external rotation with the arm at the side in adduction and at 90 degrees of abduction in the scapular plane, and active internal rotation measured by highest vertebral level reached with thumb

  3. Patient-reported functional outcome- American Shoulder and Elbow Surgeons Score [ Time Frame: up to two years postoperatively ]
    American Shoulder and Elbow Surgeons (ASES). Survey is scored 0 to 100 with 0 being the lowest possible score indicating a poor outcome and 100 being the highest possible score and indicating a good outcome.

  4. Patient-reported functional outcome- Single Assessment Numeric Evaluation score [ Time Frame: up to two years postoperatively ]
    Single Assessment Numeric Evaluation (SANE) score. Survey is scored 0 to 100 with 0 being the lowest possible score indicating a poor outcome and 100 being the highest possible score and indicating a good outcome.


Secondary Outcome Measures :
  1. Complication rates [ Time Frame: up to 2 years postoperatively ]
    acromial stress fractures and shoulder dislocations monitored by patient report through phone calls, patient visits, clinical exams, and standard of care imaging. All complications will be combined as a composite measure.

  2. Cost of Care [ Time Frame: up to 2 years after surgery ]
    reimbursement for therapy services, total number of therapy visits, estimated travel time per visit, and associated costs. These measures will be combined in a cost-effectiveness analysis with a decision tree model.

  3. Quality adjusted life years: PROMIS-29 [ Time Frame: up to 2 years postoperatively ]
    assessed using Patient-Reported Outcomes Measurement Information System-29. PROMIS Profile instruments are a collection of short forms containing a fixed number of items from seven PROMIS domains (Depression, Anxiety, Physical Function, Pain Interference, Fatigue, Sleep Disturbance, and Ability to Participate in Social Roles and Activities).The PROMIS-29 assesses each of the 7 domains with 4 questions. Each of the 7 domains has a raw score range from 4 to 20 with 4 being the lowest score, indicating a poor outcome and 20 being the highest score, indicating a good outcome.(PROMIS-29) surveys

  4. Postoperative Pain Medication Use Duration [ Time Frame: up to two years postoperatively ]
    duration of narcotic medication usage as documented in the Illinois Prescription Monitoring Program (Illinois PMP) or equivalent monitoring program for non-Rush centers

  5. Postoperative Pain Medication Prescription Refills [ Time Frame: up to two years postoperatively ]
    number of narcotic medication prescription refills as documented in the Illinois Prescription Monitoring Program (Illinois PMP) or equivalent monitoring program for non-Rush centers



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects who have RSA for cuff tear arthropathy, massive irreparable rotator cuff tear with pseudoparalysis, or primary osteoarthritis.

Exclusion Criteria:

  • Subjects who have a non-reverse total shoulder arthroplasty, RSA for fracture, tendon transfers as part of RSA, and revision RSA
  • Subjects who had RSA and require discharge to skilled nursing facility, in-patient rehabilitation placement, or use of home health therapy prior to progressing in recovery
  • Subjects who cannot speak, read, or write the English language
  • Subjects who have cognitive deficits limiting ability to follow directions
  • Subjects who have inability to attend physical therapy (i.e. transportation or financial limitations)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03719859


Contacts
Layout table for location contacts
Contact: Amanda J Naylor, MA 3124322337 shoulder.research@rushortho.com

Locations
Layout table for location information
United States, Colorado
Western Orthopaedics Not yet recruiting
Denver, Colorado, United States, 80218
Contact: Benjamin Sears, MD         
Contact: Armodios Hatzidakis, MD         
United States, District of Columbia
Medstar Georgetown University Hospital Not yet recruiting
Washington, District of Columbia, United States, 20007
Contact: Brent Wiesel, MD         
United States, Illinois
Rush University Medical Center Recruiting
Chicago, Illinois, United States, 60612
Contact: Amanda J Naylor, MA    312-432-2337    shoulder.research@rushortho.com   
Contact: Kassandra Blanchard, MA    3124322452    nicholson.research@rushortho.com   
Principal Investigator: Grant E Garrigues, MD         
Sub-Investigator: Gregory P Nicholson, MD         
Sub-Investigator: Nikhil N Verma, MD         
Sub-Investigator: Brian J Cole, MD         
United States, Maryland
Centers for Advanced Orthopaedics Not yet recruiting
Leonardtown, Maryland, United States, 20650
Contact: Peter S Johnston, MD         
United States, Massachusetts
New England Baptist Hospital Not yet recruiting
Dedham, Massachusetts, United States, 02026
Contact: Andrew Jawa, MD         
United States, Ohio
University Hospitals Cleveland Medical Center Not yet recruiting
Cleveland, Ohio, United States, 44106
Contact: Robert Gillespie, MD         
United States, Virginia
Anderson Orthopedic Clinic Not yet recruiting
Arlington, Virginia, United States, 22206
Contact: Sameer Nagda, MD         
Sponsors and Collaborators
Rush University Medical Center
Orthopedic Research and Education Foundation
Investigators
Layout table for investigator information
Principal Investigator: Grant E Garrigues, MD Rush University Medical Center
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Rush University Medical Center
ClinicalTrials.gov Identifier: NCT03719859    
Other Study ID Numbers: 18082102
First Posted: October 25, 2018    Key Record Dates
Last Update Posted: October 6, 2020
Last Verified: October 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Rush University Medical Center:
reverse total shoulder arthroplasty
physical therapy
Additional relevant MeSH terms:
Layout table for MeSH terms
Rotator Cuff Tear Arthropathy
Rotator Cuff Injuries
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rupture
Wounds and Injuries
Shoulder Injuries
Tendon Injuries
Chondrocalcinosis
Crystal Arthropathies